I hope the conservative estimate is at least large enough to pay for ongoing AXIM business so the selling of shares can stop.
AXIM has some level of financial commitment to ASU & Dr Doug Lake cancer research (which includes the testing relationship with the Arizona Mayo Clinic).
The AXIM EYE medical advisory board contains many of the heavy hitters in this Dry Eye Disease space. Why would they lend their name and reputation to a small biotech start-up company unless they were true believers.
Market Data 
Markets 
AI
